C11-Erlotinib PET/CT as a Tool for Identification and Characterization of Tumor With High Expression of Epidermal Growth Factor Receptor(EGFR).
Clinical trial NCT01717807 · UNKNOWN
Trial details
- NCT number
- NCT01717807
- Sponsor
- Hadassah Medical Organization
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2013-04-01
- Primary completion
- 2014-04-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.